nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A7—Progesterone—uterine cancer	0.0732	0.154	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0732	0.154	CbGbCtD
Quetiapine—CYP3A5—Progesterone—uterine cancer	0.0549	0.116	CbGbCtD
Quetiapine—CYP2C19—Progesterone—uterine cancer	0.0443	0.0933	CbGbCtD
Quetiapine—ABCB1—Progesterone—uterine cancer	0.0357	0.0752	CbGbCtD
Quetiapine—CYP2D6—Progesterone—uterine cancer	0.0337	0.0709	CbGbCtD
Quetiapine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0323	0.0681	CbGbCtD
Quetiapine—ABCB1—Dactinomycin—uterine cancer	0.0283	0.0597	CbGbCtD
Quetiapine—CYP3A5—Etoposide—uterine cancer	0.0246	0.0517	CbGbCtD
Quetiapine—CYP3A4—Progesterone—uterine cancer	0.0214	0.0451	CbGbCtD
Quetiapine—ABCB1—Etoposide—uterine cancer	0.016	0.0337	CbGbCtD
Quetiapine—CHRM3—ureter—uterine cancer	0.0111	0.0958	CbGeAlD
Quetiapine—ABCB1—Doxorubicin—uterine cancer	0.0109	0.023	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—uterine cancer	0.0103	0.0216	CbGbCtD
Quetiapine—CYP3A4—Etoposide—uterine cancer	0.00958	0.0202	CbGbCtD
Quetiapine—CHRM3—muscle of abdomen—uterine cancer	0.00802	0.0689	CbGeAlD
Quetiapine—H1F0—semen—uterine cancer	0.008	0.0687	CbGeAlD
Quetiapine—CYP3A4—Doxorubicin—uterine cancer	0.00653	0.0138	CbGbCtD
Quetiapine—H1F0—oviduct—uterine cancer	0.00587	0.0504	CbGeAlD
Quetiapine—HTR1E—myometrium—uterine cancer	0.00318	0.0273	CbGeAlD
Quetiapine—HTR1B—artery—uterine cancer	0.00311	0.0267	CbGeAlD
Quetiapine—HTR1D—artery—uterine cancer	0.00301	0.0259	CbGeAlD
Quetiapine—HTR7—artery—uterine cancer	0.0024	0.0206	CbGeAlD
Quetiapine—CHRM3—exocrine gland—uterine cancer	0.0022	0.0189	CbGeAlD
Quetiapine—H1F0—myometrium—uterine cancer	0.00188	0.0161	CbGeAlD
Quetiapine—CHRM5—epithelium—uterine cancer	0.00171	0.0147	CbGeAlD
Quetiapine—HTR1E—female gonad—uterine cancer	0.00168	0.0145	CbGeAlD
Quetiapine—ADRA1D—epithelium—uterine cancer	0.00153	0.0131	CbGeAlD
Quetiapine—HTR2A—artery—uterine cancer	0.0015	0.0128	CbGeAlD
Quetiapine—H1F0—uterine cervix—uterine cancer	0.00146	0.0126	CbGeAlD
Quetiapine—ADRA1B—renal system—uterine cancer	0.00145	0.0124	CbGeAlD
Quetiapine—H1F0—smooth muscle tissue—uterine cancer	0.00142	0.0122	CbGeAlD
Quetiapine—DRD5—female reproductive system—uterine cancer	0.00141	0.0122	CbGeAlD
Quetiapine—H1F0—decidua—uterine cancer	0.00139	0.012	CbGeAlD
Quetiapine—H1F0—renal system—uterine cancer	0.00137	0.0117	CbGeAlD
Quetiapine—H1F0—endometrium—uterine cancer	0.00132	0.0114	CbGeAlD
Quetiapine—DRD5—female gonad—uterine cancer	0.00129	0.0111	CbGeAlD
Quetiapine—H1F0—mammalian vulva—uterine cancer	0.00128	0.011	CbGeAlD
Quetiapine—H1F0—uterus—uterine cancer	0.00122	0.0105	CbGeAlD
Quetiapine—ADRA1D—female reproductive system—uterine cancer	0.00113	0.00975	CbGeAlD
Quetiapine—H1F0—female reproductive system—uterine cancer	0.00109	0.0094	CbGeAlD
Quetiapine—ADRA2C—myometrium—uterine cancer	0.00106	0.00915	CbGeAlD
Quetiapine—H1F0—female gonad—uterine cancer	0.000996	0.00856	CbGeAlD
Quetiapine—H1F0—vagina—uterine cancer	0.00099	0.00851	CbGeAlD
Quetiapine—CHRM3—smooth muscle tissue—uterine cancer	0.00092	0.00791	CbGeAlD
Quetiapine—HTR7—epithelium—uterine cancer	0.000909	0.00781	CbGeAlD
Quetiapine—CHRM3—renal system—uterine cancer	0.000886	0.00761	CbGeAlD
Quetiapine—HTR1A—renal system—uterine cancer	0.000882	0.00758	CbGeAlD
Quetiapine—ADRA1A—epithelium—uterine cancer	0.000877	0.00754	CbGeAlD
Quetiapine—HTR7—smooth muscle tissue—uterine cancer	0.000876	0.00753	CbGeAlD
Quetiapine—HTR1B—female reproductive system—uterine cancer	0.000876	0.00752	CbGeAlD
Quetiapine—HRH1—myometrium—uterine cancer	0.000865	0.00743	CbGeAlD
Quetiapine—ADRA2A—myometrium—uterine cancer	0.00085	0.0073	CbGeAlD
Quetiapine—HTR1D—female reproductive system—uterine cancer	0.000848	0.00729	CbGeAlD
Quetiapine—HTR7—renal system—uterine cancer	0.000843	0.00725	CbGeAlD
Quetiapine—HTR2C—female reproductive system—uterine cancer	0.00084	0.00721	CbGeAlD
Quetiapine—ADRA2C—uterine cervix—uterine cancer	0.000829	0.00712	CbGeAlD
Quetiapine—ADRA1A—renal system—uterine cancer	0.000813	0.00699	CbGeAlD
Quetiapine—CHRM1—female reproductive system—uterine cancer	0.000793	0.00681	CbGeAlD
Quetiapine—ADRA2C—decidua—uterine cancer	0.000789	0.00678	CbGeAlD
Quetiapine—ADRA2C—renal system—uterine cancer	0.000775	0.00666	CbGeAlD
Quetiapine—ADRA2C—endometrium—uterine cancer	0.000749	0.00644	CbGeAlD
Quetiapine—ADRA2C—mammalian vulva—uterine cancer	0.000725	0.00623	CbGeAlD
Quetiapine—CHRM3—female reproductive system—uterine cancer	0.00071	0.0061	CbGeAlD
Quetiapine—CYP3A5—uterine cervix—uterine cancer	0.000693	0.00596	CbGeAlD
Quetiapine—ADRA2C—uterus—uterine cancer	0.000691	0.00593	CbGeAlD
Quetiapine—HRH1—epithelium—uterine cancer	0.000679	0.00583	CbGeAlD
Quetiapine—HTR7—female reproductive system—uterine cancer	0.000675	0.0058	CbGeAlD
Quetiapine—HRH1—uterine cervix—uterine cancer	0.000673	0.00578	CbGeAlD
Quetiapine—ADRA2A—uterine cervix—uterine cancer	0.000661	0.00568	CbGeAlD
Quetiapine—HRH1—smooth muscle tissue—uterine cancer	0.000654	0.00562	CbGeAlD
Quetiapine—CYP3A5—renal system—uterine cancer	0.000649	0.00557	CbGeAlD
Quetiapine—CHRM3—female gonad—uterine cancer	0.000646	0.00555	CbGeAlD
Quetiapine—HRH1—decidua—uterine cancer	0.000641	0.00551	CbGeAlD
Quetiapine—H1F0—lymph node—uterine cancer	0.00064	0.0055	CbGeAlD
Quetiapine—ADRA2A—decidua—uterine cancer	0.00063	0.00541	CbGeAlD
Quetiapine—HRH1—endometrium—uterine cancer	0.000609	0.00523	CbGeAlD
Quetiapine—ADRA2A—endometrium—uterine cancer	0.000598	0.00514	CbGeAlD
Quetiapine—CYP2C19—vagina—uterine cancer	0.000597	0.00513	CbGeAlD
Quetiapine—HRH1—mammalian vulva—uterine cancer	0.000589	0.00506	CbGeAlD
Quetiapine—ADRA2A—mammalian vulva—uterine cancer	0.000578	0.00497	CbGeAlD
Quetiapine—HTR2A—epithelium—uterine cancer	0.000567	0.00487	CbGeAlD
Quetiapine—ADRA2C—female gonad—uterine cancer	0.000565	0.00485	CbGeAlD
Quetiapine—ADRA2C—vagina—uterine cancer	0.000561	0.00482	CbGeAlD
Quetiapine—ADRA2A—uterus—uterine cancer	0.000551	0.00473	CbGeAlD
Quetiapine—HTR2A—smooth muscle tissue—uterine cancer	0.000546	0.00469	CbGeAlD
Quetiapine—HTR2A—renal system—uterine cancer	0.000526	0.00452	CbGeAlD
Quetiapine—HRH1—female reproductive system—uterine cancer	0.000504	0.00433	CbGeAlD
Quetiapine—ADRA2A—female reproductive system—uterine cancer	0.000495	0.00426	CbGeAlD
Quetiapine—CYP3A4—renal system—uterine cancer	0.000487	0.00418	CbGeAlD
Quetiapine—CYP2D6—renal system—uterine cancer	0.000479	0.00412	CbGeAlD
Quetiapine—ABCB1—myometrium—uterine cancer	0.000473	0.00407	CbGeAlD
Quetiapine—CYP3A5—female gonad—uterine cancer	0.000473	0.00406	CbGeAlD
Quetiapine—CYP3A5—vagina—uterine cancer	0.00047	0.00404	CbGeAlD
Quetiapine—HRH1—female gonad—uterine cancer	0.000459	0.00394	CbGeAlD
Quetiapine—HRH1—vagina—uterine cancer	0.000456	0.00392	CbGeAlD
Quetiapine—ADRA2A—female gonad—uterine cancer	0.000451	0.00387	CbGeAlD
Quetiapine—ADRA2A—vagina—uterine cancer	0.000448	0.00385	CbGeAlD
Quetiapine—HTR2A—female reproductive system—uterine cancer	0.000421	0.00362	CbGeAlD
Quetiapine—CYP3A4—female reproductive system—uterine cancer	0.00039	0.00335	CbGeAlD
Quetiapine—CYP2D6—female reproductive system—uterine cancer	0.000384	0.0033	CbGeAlD
Quetiapine—HTR2A—vagina—uterine cancer	0.000381	0.00327	CbGeAlD
Quetiapine—ABCB1—epithelium—uterine cancer	0.000372	0.00319	CbGeAlD
Quetiapine—ABCB1—uterine cervix—uterine cancer	0.000368	0.00317	CbGeAlD
Quetiapine—ADRA2C—lymph node—uterine cancer	0.000363	0.00312	CbGeAlD
Quetiapine—ABCB1—decidua—uterine cancer	0.000351	0.00302	CbGeAlD
Quetiapine—CYP2D6—female gonad—uterine cancer	0.000349	0.003	CbGeAlD
Quetiapine—ABCB1—renal system—uterine cancer	0.000345	0.00296	CbGeAlD
Quetiapine—ABCB1—endometrium—uterine cancer	0.000333	0.00286	CbGeAlD
Quetiapine—ABCB1—mammalian vulva—uterine cancer	0.000322	0.00277	CbGeAlD
Quetiapine—ABCB1—uterus—uterine cancer	0.000307	0.00264	CbGeAlD
Quetiapine—HRH1—lymph node—uterine cancer	0.000295	0.00253	CbGeAlD
Quetiapine—ADRA2A—lymph node—uterine cancer	0.00029	0.00249	CbGeAlD
Quetiapine—ABCB1—female reproductive system—uterine cancer	0.000276	0.00237	CbGeAlD
Quetiapine—ABCB1—female gonad—uterine cancer	0.000251	0.00216	CbGeAlD
Quetiapine—ABCB1—vagina—uterine cancer	0.00025	0.00214	CbGeAlD
Quetiapine—ABCB1—lymph node—uterine cancer	0.000161	0.00139	CbGeAlD
Quetiapine—Bronchitis—Epirubicin—uterine cancer	0.000157	0.000427	CcSEcCtD
Quetiapine—Diarrhoea—Dactinomycin—uterine cancer	0.000157	0.000426	CcSEcCtD
Quetiapine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000156	0.000425	CcSEcCtD
Quetiapine—Hypotension—Etoposide—uterine cancer	0.000155	0.000421	CcSEcCtD
Quetiapine—Gastritis—Doxorubicin—uterine cancer	0.000155	0.000421	CcSEcCtD
Quetiapine—Muscular weakness—Doxorubicin—uterine cancer	0.000154	0.000419	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000154	0.000419	CcSEcCtD
Quetiapine—Dysuria—Epirubicin—uterine cancer	0.000153	0.000415	CcSEcCtD
Quetiapine—Neutropenia—Epirubicin—uterine cancer	0.000153	0.000415	CcSEcCtD
Quetiapine—Abdominal distension—Doxorubicin—uterine cancer	0.000152	0.000413	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000152	0.000412	CcSEcCtD
Quetiapine—Asthma—Doxorubicin—uterine cancer	0.000151	0.000411	CcSEcCtD
Quetiapine—Dysphagia—Doxorubicin—uterine cancer	0.000151	0.000411	CcSEcCtD
Quetiapine—Influenza—Doxorubicin—uterine cancer	0.000151	0.000411	CcSEcCtD
Quetiapine—Pollakiuria—Epirubicin—uterine cancer	0.000151	0.00041	CcSEcCtD
Quetiapine—Eosinophilia—Doxorubicin—uterine cancer	0.00015	0.000407	CcSEcCtD
Quetiapine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000149	0.000405	CcSEcCtD
Quetiapine—Paraesthesia—Etoposide—uterine cancer	0.000149	0.000404	CcSEcCtD
Quetiapine—Weight increased—Epirubicin—uterine cancer	0.000149	0.000404	CcSEcCtD
Quetiapine—Pancreatitis—Doxorubicin—uterine cancer	0.000148	0.000403	CcSEcCtD
Quetiapine—Weight decreased—Epirubicin—uterine cancer	0.000148	0.000402	CcSEcCtD
Quetiapine—Dyspnoea—Etoposide—uterine cancer	0.000148	0.000401	CcSEcCtD
Quetiapine—Hyperglycaemia—Epirubicin—uterine cancer	0.000147	0.0004	CcSEcCtD
Quetiapine—Somnolence—Etoposide—uterine cancer	0.000147	0.0004	CcSEcCtD
Quetiapine—Angina pectoris—Doxorubicin—uterine cancer	0.000147	0.0004	CcSEcCtD
Quetiapine—Pneumonia—Epirubicin—uterine cancer	0.000146	0.000398	CcSEcCtD
Quetiapine—Infestation—Epirubicin—uterine cancer	0.000146	0.000396	CcSEcCtD
Quetiapine—Infestation NOS—Epirubicin—uterine cancer	0.000146	0.000396	CcSEcCtD
Quetiapine—Vomiting—Dactinomycin—uterine cancer	0.000146	0.000396	CcSEcCtD
Quetiapine—Bronchitis—Doxorubicin—uterine cancer	0.000145	0.000395	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000144	0.000392	CcSEcCtD
Quetiapine—Rash—Dactinomycin—uterine cancer	0.000144	0.000392	CcSEcCtD
Quetiapine—Decreased appetite—Etoposide—uterine cancer	0.000144	0.000391	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000143	0.000389	CcSEcCtD
Quetiapine—Fatigue—Etoposide—uterine cancer	0.000143	0.000388	CcSEcCtD
Quetiapine—Stomatitis—Epirubicin—uterine cancer	0.000142	0.000386	CcSEcCtD
Quetiapine—Jaundice—Epirubicin—uterine cancer	0.000142	0.000386	CcSEcCtD
Quetiapine—Constipation—Etoposide—uterine cancer	0.000142	0.000385	CcSEcCtD
Quetiapine—Pain—Etoposide—uterine cancer	0.000142	0.000385	CcSEcCtD
Quetiapine—Conjunctivitis—Epirubicin—uterine cancer	0.000142	0.000385	CcSEcCtD
Quetiapine—Urinary tract infection—Epirubicin—uterine cancer	0.000142	0.000385	CcSEcCtD
Quetiapine—Neutropenia—Doxorubicin—uterine cancer	0.000141	0.000384	CcSEcCtD
Quetiapine—Dysuria—Doxorubicin—uterine cancer	0.000141	0.000384	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00014	0.000382	CcSEcCtD
Quetiapine—Sweating—Epirubicin—uterine cancer	0.00014	0.000379	CcSEcCtD
Quetiapine—Pollakiuria—Doxorubicin—uterine cancer	0.00014	0.000379	CcSEcCtD
Quetiapine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000138	0.000375	CcSEcCtD
Quetiapine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000138	0.000374	CcSEcCtD
Quetiapine—Weight increased—Doxorubicin—uterine cancer	0.000138	0.000374	CcSEcCtD
Quetiapine—Epistaxis—Epirubicin—uterine cancer	0.000137	0.000373	CcSEcCtD
Quetiapine—Weight decreased—Doxorubicin—uterine cancer	0.000137	0.000372	CcSEcCtD
Quetiapine—Sinusitis—Epirubicin—uterine cancer	0.000137	0.000371	CcSEcCtD
Quetiapine—Feeling abnormal—Etoposide—uterine cancer	0.000137	0.000371	CcSEcCtD
Quetiapine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000136	0.00037	CcSEcCtD
Quetiapine—Nausea—Dactinomycin—uterine cancer	0.000136	0.00037	CcSEcCtD
Quetiapine—Agranulocytosis—Epirubicin—uterine cancer	0.000136	0.000369	CcSEcCtD
Quetiapine—Pneumonia—Doxorubicin—uterine cancer	0.000136	0.000368	CcSEcCtD
Quetiapine—Gastrointestinal pain—Etoposide—uterine cancer	0.000135	0.000368	CcSEcCtD
Quetiapine—Infestation—Doxorubicin—uterine cancer	0.000135	0.000366	CcSEcCtD
Quetiapine—Infestation NOS—Doxorubicin—uterine cancer	0.000135	0.000366	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000134	0.000363	CcSEcCtD
Quetiapine—Bradycardia—Epirubicin—uterine cancer	0.000133	0.000362	CcSEcCtD
Quetiapine—Haemoglobin—Epirubicin—uterine cancer	0.000131	0.000357	CcSEcCtD
Quetiapine—Stomatitis—Doxorubicin—uterine cancer	0.000131	0.000357	CcSEcCtD
Quetiapine—Jaundice—Doxorubicin—uterine cancer	0.000131	0.000357	CcSEcCtD
Quetiapine—Rhinitis—Epirubicin—uterine cancer	0.000131	0.000356	CcSEcCtD
Quetiapine—Abdominal pain—Etoposide—uterine cancer	0.000131	0.000356	CcSEcCtD
Quetiapine—Body temperature increased—Etoposide—uterine cancer	0.000131	0.000356	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—uterine cancer	0.000131	0.000356	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—uterine cancer	0.000131	0.000356	CcSEcCtD
Quetiapine—Haemorrhage—Epirubicin—uterine cancer	0.000131	0.000355	CcSEcCtD
Quetiapine—Hepatitis—Epirubicin—uterine cancer	0.000131	0.000355	CcSEcCtD
Quetiapine—Hypoaesthesia—Epirubicin—uterine cancer	0.00013	0.000353	CcSEcCtD
Quetiapine—Pharyngitis—Epirubicin—uterine cancer	0.00013	0.000353	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—uterine cancer	0.000129	0.000351	CcSEcCtD
Quetiapine—Urinary tract disorder—Epirubicin—uterine cancer	0.000129	0.000351	CcSEcCtD
Quetiapine—Oedema peripheral—Epirubicin—uterine cancer	0.000129	0.00035	CcSEcCtD
Quetiapine—Connective tissue disorder—Epirubicin—uterine cancer	0.000128	0.000349	CcSEcCtD
Quetiapine—Urethral disorder—Epirubicin—uterine cancer	0.000128	0.000348	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000127	0.000346	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—uterine cancer	0.000127	0.000345	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—uterine cancer	0.000126	0.000344	CcSEcCtD
Quetiapine—Visual impairment—Epirubicin—uterine cancer	0.000126	0.000342	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—uterine cancer	0.000126	0.000342	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—uterine cancer	0.000124	0.000336	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—uterine cancer	0.000123	0.000335	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—uterine cancer	0.000122	0.000332	CcSEcCtD
Quetiapine—Hypersensitivity—Etoposide—uterine cancer	0.000122	0.000332	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—uterine cancer	0.000122	0.000331	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—uterine cancer	0.000122	0.00033	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—uterine cancer	0.000121	0.00033	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—uterine cancer	0.000121	0.00033	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—uterine cancer	0.000121	0.000329	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—uterine cancer	0.000121	0.000329	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—uterine cancer	0.00012	0.000327	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—uterine cancer	0.00012	0.000326	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000119	0.000325	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—uterine cancer	0.000119	0.000324	CcSEcCtD
Quetiapine—Asthenia—Etoposide—uterine cancer	0.000119	0.000323	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000119	0.000323	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—uterine cancer	0.000119	0.000322	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—uterine cancer	0.000119	0.000322	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—uterine cancer	0.000118	0.000321	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—uterine cancer	0.000118	0.00032	CcSEcCtD
Quetiapine—Chills—Epirubicin—uterine cancer	0.000117	0.000319	CcSEcCtD
Quetiapine—Pruritus—Etoposide—uterine cancer	0.000117	0.000319	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—uterine cancer	0.000117	0.000317	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—uterine cancer	0.000115	0.000311	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—uterine cancer	0.000114	0.000311	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—uterine cancer	0.000114	0.000309	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—uterine cancer	0.000113	0.000308	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—uterine cancer	0.000113	0.000307	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—uterine cancer	0.000113	0.000306	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—uterine cancer	0.000112	0.000305	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—uterine cancer	0.000112	0.000305	CcSEcCtD
Quetiapine—Tension—Epirubicin—uterine cancer	0.000112	0.000303	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—uterine cancer	0.000111	0.000303	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—uterine cancer	0.000111	0.0003	CcSEcCtD
Quetiapine—Back pain—Epirubicin—uterine cancer	0.00011	0.000299	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—uterine cancer	0.00011	0.000298	CcSEcCtD
Quetiapine—Dizziness—Etoposide—uterine cancer	0.00011	0.000298	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—uterine cancer	0.000109	0.000297	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—uterine cancer	0.000109	0.000297	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000109	0.000296	CcSEcCtD
Quetiapine—Chills—Doxorubicin—uterine cancer	0.000109	0.000295	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—uterine cancer	0.000107	0.000291	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—uterine cancer	0.000106	0.000288	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—uterine cancer	0.000106	0.000287	CcSEcCtD
Quetiapine—Vomiting—Etoposide—uterine cancer	0.000105	0.000286	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—uterine cancer	0.000105	0.000286	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—uterine cancer	0.000105	0.000286	CcSEcCtD
Quetiapine—Agitation—Epirubicin—uterine cancer	0.000105	0.000284	CcSEcCtD
Quetiapine—Rash—Etoposide—uterine cancer	0.000104	0.000284	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—uterine cancer	0.000104	0.000284	CcSEcCtD
Quetiapine—Headache—Etoposide—uterine cancer	0.000104	0.000282	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—uterine cancer	0.000104	0.000282	CcSEcCtD
Quetiapine—Tension—Doxorubicin—uterine cancer	0.000103	0.000281	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—uterine cancer	0.000103	0.00028	CcSEcCtD
Quetiapine—Malaise—Epirubicin—uterine cancer	0.000103	0.000279	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—uterine cancer	0.000102	0.000278	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—uterine cancer	0.000102	0.000278	CcSEcCtD
Quetiapine—Syncope—Epirubicin—uterine cancer	0.000102	0.000277	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—uterine cancer	0.000102	0.000277	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—uterine cancer	0.000102	0.000277	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—uterine cancer	0.000101	0.000275	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—uterine cancer	0.000101	0.000273	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—uterine cancer	0.0001	0.000272	CcSEcCtD
Quetiapine—Cough—Epirubicin—uterine cancer	9.93e-05	0.00027	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—uterine cancer	9.92e-05	0.00027	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—uterine cancer	9.86e-05	0.000268	CcSEcCtD
Quetiapine—Nausea—Etoposide—uterine cancer	9.84e-05	0.000267	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—uterine cancer	9.82e-05	0.000267	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—uterine cancer	9.77e-05	0.000265	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—uterine cancer	9.73e-05	0.000264	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—uterine cancer	9.69e-05	0.000263	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—uterine cancer	9.69e-05	0.000263	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—uterine cancer	9.69e-05	0.000263	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—uterine cancer	9.68e-05	0.000263	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—uterine cancer	9.65e-05	0.000262	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	9.62e-05	0.000261	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—uterine cancer	9.57e-05	0.00026	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—uterine cancer	9.49e-05	0.000258	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—uterine cancer	9.47e-05	0.000257	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—uterine cancer	9.46e-05	0.000257	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—uterine cancer	9.44e-05	0.000257	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—uterine cancer	9.42e-05	0.000256	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—uterine cancer	9.36e-05	0.000254	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—uterine cancer	9.3e-05	0.000253	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—uterine cancer	9.29e-05	0.000252	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—uterine cancer	9.25e-05	0.000251	CcSEcCtD
Quetiapine—Infection—Epirubicin—uterine cancer	9.23e-05	0.000251	CcSEcCtD
Quetiapine—Cough—Doxorubicin—uterine cancer	9.19e-05	0.00025	CcSEcCtD
Quetiapine—Shock—Epirubicin—uterine cancer	9.14e-05	0.000248	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—uterine cancer	9.12e-05	0.000248	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—uterine cancer	9.11e-05	0.000248	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—uterine cancer	9.09e-05	0.000247	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—uterine cancer	9.09e-05	0.000247	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—uterine cancer	9.06e-05	0.000246	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—uterine cancer	9.02e-05	0.000245	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—uterine cancer	8.98e-05	0.000244	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—uterine cancer	8.96e-05	0.000244	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—uterine cancer	8.96e-05	0.000244	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—uterine cancer	8.96e-05	0.000244	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—uterine cancer	8.93e-05	0.000243	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	8.9e-05	0.000242	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—uterine cancer	8.86e-05	0.000241	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—uterine cancer	8.85e-05	0.000241	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—uterine cancer	8.77e-05	0.000238	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—uterine cancer	8.68e-05	0.000236	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—uterine cancer	8.66e-05	0.000235	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—uterine cancer	8.59e-05	0.000234	CcSEcCtD
Quetiapine—Infection—Doxorubicin—uterine cancer	8.54e-05	0.000232	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—uterine cancer	8.46e-05	0.00023	CcSEcCtD
Quetiapine—Shock—Doxorubicin—uterine cancer	8.45e-05	0.00023	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—uterine cancer	8.43e-05	0.000229	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—uterine cancer	8.41e-05	0.000229	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—uterine cancer	8.4e-05	0.000228	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—uterine cancer	8.39e-05	0.000228	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—uterine cancer	8.35e-05	0.000227	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—uterine cancer	8.34e-05	0.000227	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—uterine cancer	8.31e-05	0.000226	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—uterine cancer	8.28e-05	0.000225	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—uterine cancer	8.26e-05	0.000224	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—uterine cancer	8.19e-05	0.000223	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—uterine cancer	8.17e-05	0.000222	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—uterine cancer	8.07e-05	0.000219	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—uterine cancer	8.03e-05	0.000218	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—uterine cancer	8.02e-05	0.000218	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—uterine cancer	8.01e-05	0.000218	CcSEcCtD
Quetiapine—Constipation—Epirubicin—uterine cancer	7.94e-05	0.000216	CcSEcCtD
Quetiapine—Pain—Epirubicin—uterine cancer	7.94e-05	0.000216	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	7.83e-05	0.000213	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—uterine cancer	7.77e-05	0.000211	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—uterine cancer	7.72e-05	0.00021	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—uterine cancer	7.66e-05	0.000208	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—uterine cancer	7.65e-05	0.000208	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—uterine cancer	7.64e-05	0.000208	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—uterine cancer	7.59e-05	0.000206	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—uterine cancer	7.56e-05	0.000206	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—uterine cancer	7.47e-05	0.000203	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.42e-05	0.000202	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—uterine cancer	7.41e-05	0.000201	CcSEcCtD
Quetiapine—Pain—Doxorubicin—uterine cancer	7.35e-05	0.0002	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—uterine cancer	7.35e-05	0.0002	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—uterine cancer	7.34e-05	0.0002	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—uterine cancer	7.34e-05	0.0002	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—uterine cancer	7.08e-05	0.000192	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—uterine cancer	7.03e-05	0.000191	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—uterine cancer	6.84e-05	0.000186	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—uterine cancer	6.79e-05	0.000185	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—uterine cancer	6.79e-05	0.000185	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—uterine cancer	6.66e-05	0.000181	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—uterine cancer	6.57e-05	0.000179	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—uterine cancer	6.35e-05	0.000173	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—uterine cancer	6.33e-05	0.000172	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—uterine cancer	6.16e-05	0.000168	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—uterine cancer	6.14e-05	0.000167	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—uterine cancer	6.08e-05	0.000165	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—uterine cancer	5.9e-05	0.00016	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—uterine cancer	5.88e-05	0.00016	CcSEcCtD
Quetiapine—Rash—Epirubicin—uterine cancer	5.86e-05	0.000159	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—uterine cancer	5.85e-05	0.000159	CcSEcCtD
Quetiapine—Headache—Epirubicin—uterine cancer	5.82e-05	0.000158	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—uterine cancer	5.68e-05	0.000154	CcSEcCtD
Quetiapine—Nausea—Epirubicin—uterine cancer	5.52e-05	0.00015	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—uterine cancer	5.46e-05	0.000148	CcSEcCtD
Quetiapine—Rash—Doxorubicin—uterine cancer	5.42e-05	0.000147	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—uterine cancer	5.41e-05	0.000147	CcSEcCtD
Quetiapine—Headache—Doxorubicin—uterine cancer	5.38e-05	0.000146	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—uterine cancer	5.1e-05	0.000139	CcSEcCtD
Quetiapine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	4.41e-06	0.000108	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KRAS—uterine cancer	4.41e-06	0.000108	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EP300—uterine cancer	4.39e-06	0.000108	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KRAS—uterine cancer	4.35e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	4.35e-06	0.000107	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—EP300—uterine cancer	4.34e-06	0.000107	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—uterine cancer	4.34e-06	0.000107	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—uterine cancer	4.34e-06	0.000106	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.32e-06	0.000106	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HRAS—uterine cancer	4.31e-06	0.000106	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PTEN—uterine cancer	4.3e-06	0.000106	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	4.27e-06	0.000105	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—uterine cancer	4.26e-06	0.000105	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.26e-06	0.000105	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—STK11—uterine cancer	4.26e-06	0.000105	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—uterine cancer	4.25e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	4.25e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EP300—uterine cancer	4.24e-06	0.000104	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	4.24e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—PIK3CA—uterine cancer	4.24e-06	0.000104	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—uterine cancer	4.24e-06	0.000104	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HRAS—uterine cancer	4.24e-06	0.000104	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	4.24e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—PIK3CA—uterine cancer	4.23e-06	0.000104	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HRAS—uterine cancer	4.22e-06	0.000104	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EP300—uterine cancer	4.22e-06	0.000104	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HRAS—uterine cancer	4.21e-06	0.000103	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—PIK3CA—uterine cancer	4.21e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	4.2e-06	0.000103	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	4.2e-06	0.000103	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	4.19e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	4.18e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTEN—uterine cancer	4.18e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	4.17e-06	0.000102	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	4.17e-06	0.000102	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	4.17e-06	0.000102	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KRAS—uterine cancer	4.17e-06	0.000102	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	4.16e-06	0.000102	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	4.16e-06	0.000102	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	4.16e-06	0.000102	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	4.15e-06	0.000102	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	4.14e-06	0.000101	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	4.13e-06	0.000101	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	4.13e-06	0.000101	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	4.12e-06	0.000101	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—PIK3CA—uterine cancer	4.12e-06	0.000101	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NRAS—uterine cancer	4.11e-06	0.000101	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	4.11e-06	0.000101	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EP300—uterine cancer	4.1e-06	0.000101	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—uterine cancer	4.1e-06	0.000101	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	4.1e-06	0.000101	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	4.1e-06	0.0001	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—uterine cancer	4.1e-06	0.0001	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	4.09e-06	0.0001	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	4.09e-06	0.0001	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—uterine cancer	4.07e-06	9.98e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—PIK3CA—uterine cancer	4.05e-06	9.94e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	4.05e-06	9.94e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	4.04e-06	9.91e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EP300—uterine cancer	4.04e-06	9.91e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—uterine cancer	4.02e-06	9.85e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	4.01e-06	9.83e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	4e-06	9.81e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	4e-06	9.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—EP300—uterine cancer	3.99e-06	9.78e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—uterine cancer	3.98e-06	9.77e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KRAS—uterine cancer	3.97e-06	9.74e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NRAS—uterine cancer	3.97e-06	9.73e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NRAS—uterine cancer	3.95e-06	9.68e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	3.94e-06	9.67e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	3.93e-06	9.65e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HRAS—uterine cancer	3.92e-06	9.62e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	3.92e-06	9.62e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—uterine cancer	3.92e-06	9.62e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—uterine cancer	3.92e-06	9.61e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—uterine cancer	3.92e-06	9.61e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HRAS—uterine cancer	3.92e-06	9.61e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	3.91e-06	9.59e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—uterine cancer	3.9e-06	9.58e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HRAS—uterine cancer	3.89e-06	9.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	3.89e-06	9.54e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	3.89e-06	9.53e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	3.87e-06	9.49e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—uterine cancer	3.87e-06	9.49e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	3.86e-06	9.47e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	3.86e-06	9.47e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—uterine cancer	3.84e-06	9.42e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NRAS—uterine cancer	3.84e-06	9.42e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—uterine cancer	3.83e-06	9.4e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—uterine cancer	3.83e-06	9.4e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	3.83e-06	9.39e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	3.83e-06	9.38e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—uterine cancer	3.82e-06	9.37e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HRAS—uterine cancer	3.81e-06	9.35e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—uterine cancer	3.81e-06	9.34e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—uterine cancer	3.81e-06	9.34e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	3.8e-06	9.31e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	3.78e-06	9.27e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—uterine cancer	3.77e-06	9.25e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	3.76e-06	9.23e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	3.76e-06	9.21e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—uterine cancer	3.75e-06	9.2e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	3.75e-06	9.19e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—uterine cancer	3.74e-06	9.17e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—uterine cancer	3.74e-06	9.17e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—uterine cancer	3.73e-06	9.15e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—uterine cancer	3.72e-06	9.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—uterine cancer	3.72e-06	9.12e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—uterine cancer	3.7e-06	9.09e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—uterine cancer	3.7e-06	9.07e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	3.68e-06	9.03e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	3.67e-06	9e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—uterine cancer	3.66e-06	8.99e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—uterine cancer	3.66e-06	8.97e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—uterine cancer	3.65e-06	8.96e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—uterine cancer	3.65e-06	8.95e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—uterine cancer	3.64e-06	8.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—uterine cancer	3.63e-06	8.91e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—uterine cancer	3.63e-06	8.91e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—uterine cancer	3.6e-06	8.83e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	3.6e-06	8.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—uterine cancer	3.6e-06	8.82e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—uterine cancer	3.59e-06	8.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	3.59e-06	8.8e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—uterine cancer	3.54e-06	8.69e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—uterine cancer	3.54e-06	8.68e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—uterine cancer	3.53e-06	8.66e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—uterine cancer	3.53e-06	8.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	3.5e-06	8.57e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—uterine cancer	3.48e-06	8.55e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—uterine cancer	3.48e-06	8.54e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—uterine cancer	3.48e-06	8.54e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	3.47e-06	8.51e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—uterine cancer	3.46e-06	8.49e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—uterine cancer	3.46e-06	8.49e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—uterine cancer	3.46e-06	8.48e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—uterine cancer	3.45e-06	8.47e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—uterine cancer	3.44e-06	8.44e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—uterine cancer	3.44e-06	8.43e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—uterine cancer	3.43e-06	8.41e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—uterine cancer	3.42e-06	8.39e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—uterine cancer	3.42e-06	8.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	3.41e-06	8.36e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—uterine cancer	3.41e-06	8.36e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	3.41e-06	8.36e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—uterine cancer	3.4e-06	8.34e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	3.4e-06	8.34e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.4e-06	8.33e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—uterine cancer	3.38e-06	8.28e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—uterine cancer	3.37e-06	8.26e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—uterine cancer	3.36e-06	8.25e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	3.36e-06	8.23e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—uterine cancer	3.33e-06	8.18e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—uterine cancer	3.33e-06	8.17e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—uterine cancer	3.33e-06	8.17e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—uterine cancer	3.31e-06	8.12e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—uterine cancer	3.3e-06	8.11e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—uterine cancer	3.27e-06	8.01e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	3.25e-06	7.98e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	3.25e-06	7.97e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—uterine cancer	3.21e-06	7.88e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—uterine cancer	3.2e-06	7.85e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	3.16e-06	7.74e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—uterine cancer	3.14e-06	7.71e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	3.14e-06	7.7e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—uterine cancer	3.13e-06	7.67e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	3.12e-06	7.66e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	3.12e-06	7.65e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—uterine cancer	3.05e-06	7.49e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	3.04e-06	7.45e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—uterine cancer	3.04e-06	7.45e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—uterine cancer	3.02e-06	7.41e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—uterine cancer	3.01e-06	7.38e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—uterine cancer	3e-06	7.35e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	2.99e-06	7.33e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—uterine cancer	2.98e-06	7.31e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—uterine cancer	2.97e-06	7.28e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—uterine cancer	2.96e-06	7.26e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—uterine cancer	2.95e-06	7.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—uterine cancer	2.95e-06	7.23e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—uterine cancer	2.94e-06	7.22e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—uterine cancer	2.94e-06	7.21e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—uterine cancer	2.94e-06	7.21e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—uterine cancer	2.94e-06	7.2e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—uterine cancer	2.93e-06	7.2e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—uterine cancer	2.93e-06	7.18e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—uterine cancer	2.9e-06	7.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—uterine cancer	2.9e-06	7.11e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—uterine cancer	2.89e-06	7.09e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—uterine cancer	2.89e-06	7.09e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	2.89e-06	7.09e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—uterine cancer	2.89e-06	7.08e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—uterine cancer	2.82e-06	6.93e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—uterine cancer	2.81e-06	6.89e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	2.76e-06	6.78e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—uterine cancer	2.76e-06	6.76e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	2.75e-06	6.76e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—uterine cancer	2.72e-06	6.68e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	2.71e-06	6.65e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	2.7e-06	6.63e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.7e-06	6.63e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	2.7e-06	6.61e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	2.69e-06	6.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	2.68e-06	6.58e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—uterine cancer	2.66e-06	6.54e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	2.66e-06	6.53e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—uterine cancer	2.66e-06	6.51e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	2.65e-06	6.51e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—uterine cancer	2.63e-06	6.44e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—uterine cancer	2.62e-06	6.43e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—uterine cancer	2.62e-06	6.42e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—uterine cancer	2.61e-06	6.4e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—uterine cancer	2.6e-06	6.38e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—uterine cancer	2.6e-06	6.37e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—uterine cancer	2.57e-06	6.32e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—uterine cancer	2.57e-06	6.3e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—uterine cancer	2.56e-06	6.29e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.55e-06	6.25e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—uterine cancer	2.55e-06	6.25e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—uterine cancer	2.51e-06	6.15e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—uterine cancer	2.5e-06	6.14e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—uterine cancer	2.49e-06	6.12e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—uterine cancer	2.49e-06	6.1e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—uterine cancer	2.48e-06	6.08e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	2.47e-06	6.05e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—uterine cancer	2.46e-06	6.04e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	2.46e-06	6.02e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	2.44e-06	5.99e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—uterine cancer	2.41e-06	5.91e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—uterine cancer	2.39e-06	5.85e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	2.28e-06	5.6e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—uterine cancer	2.25e-06	5.52e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—uterine cancer	2.21e-06	5.43e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—uterine cancer	2.21e-06	5.42e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—uterine cancer	2.21e-06	5.42e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—uterine cancer	2.2e-06	5.4e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—uterine cancer	2.2e-06	5.39e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—uterine cancer	2.17e-06	5.33e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	2.17e-06	5.32e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.09e-06	5.13e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.04e-06	5e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	2.01e-06	4.94e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.92e-06	4.71e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—uterine cancer	1.78e-06	4.37e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—uterine cancer	1.71e-06	4.19e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—uterine cancer	1.7e-06	4.17e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—uterine cancer	1.67e-06	4.09e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—uterine cancer	1.57e-06	3.85e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.26e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—uterine cancer	1.03e-06	2.52e-05	CbGpPWpGaD
